Raymond James Financial Inc. Purchases New Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Raymond James Financial Inc. acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 601,136 shares of the medical equipment provider’s stock, valued at approximately $313,769,000. Raymond James Financial Inc. owned about 0.17% of Intuitive Surgical at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the company. M.E. Allison & CO. Inc. acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $449,000. Seilern Investment Management Ltd bought a new position in Intuitive Surgical during the fourth quarter worth about $82,517,000. Sycomore Asset Management increased its holdings in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after acquiring an additional 4,079 shares in the last quarter. Exome Asset Management LLC increased its holdings in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after acquiring an additional 1,069 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. raised its position in shares of Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Fredrik Widman sold 810 shares of the stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the sale, the vice president now owns 473 shares in the company, valued at approximately $271,397.94. This trade represents a 63.13 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 13,090 shares of company stock worth $7,496,119 in the last ninety days. Insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on ISRG. JPMorgan Chase & Co. increased their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Raymond James raised their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Bernstein Bank boosted their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. Truist Financial increased their target price on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Finally, Jefferies Financial Group boosted their price target on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Trading Down 5.2 %

NASDAQ ISRG opened at $538.57 on Friday. The firm has a market capitalization of $191.83 billion, a P/E ratio of 84.02, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The firm’s fifty day moving average price is $571.70 and its two-hundred day moving average price is $530.95. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.